Search Results

QT Alterations in Psychopharmacology: Proven Candidates and Suspects

Authors: Alvarez, Paulino A.; Pahissa, Jaime

Source: Current Drug Safety, Volume 5, Number 1, January 2010 , pp. 97-104(8)

Publisher: Bentham Science Publishers

New review challenges antipsychotic use in dementia

Source: Reactions, Volume 1, Number 1279, 2009-11-21 , pp. 3-3(1)

Publisher: Adis International

Diet blues: Methodological problems in comparing non-pharmacological weight management programs for patients with schizophrenia

Authors: Veit, Tina; Barnas, Christian

Source: International Journal of Psychiatry in Clinical Practice, Volume 13, Number 3, September 2009 , pp. 173-183(11)

Publisher: Informa Healthcare

Effectiveness and tolerability of long-acting risperidone: A 9-month open-label extension of a 12-week switching study from oral antipsychotics

Authors: Kim, Chang Yoon; Chung, Seockhoon; Hahm, Bong-Jin; Hong, Kyung Sue; Yoon, Jin-Sang; Kim, Young-Hoon; Bahk, Won-Myong; Lee, Sang-Yeol; Lee, Yanghyun; Chung, In-Won; Kim, Chan-Hyung

Source: International Journal of Psychiatry in Clinical Practice, Volume 13, Number 3, September 2009 , pp. 192-198(7)

Publisher: Informa Healthcare

Effects of Glucocorticoids on Mood, Memory, and the Hippocampus: Treatment and Preventive Therapy

Author: Brown, E. Sherwood

Source: Annals of the New York Academy of Sciences, Volume 1179, Number 1, October 2009 , pp. 41-55(15)

Publisher: Blackwell Publishing

Changes in weight and metabolic parameters during treatment with antipsychotics and metformin: do the data inform as to potential guideline development? A systematic review of clinical studies

Authors: Bushe, C. J.; Bradley, A. J.; Doshi, S.; Karagianis, J.

Source: International Journal of Clinical Practice, Volume 63, Number 12, December 2009 , pp. 1743-1761(19)

Publisher: Blackwell Publishing

Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic

Author: Citrome, L.

Source: International Journal of Clinical Practice, Volume 63, Number 12, December 2009 , pp. 1762-1784(23)

Publisher: Blackwell Publishing

Naloxone-responsive acute dystonia and parkinsonism following general anaesthesia

Authors: Iselin-Chaves, I. A.; Grötzsch, H.; Besson, M.; Burkhard, P. R.; Savoldelli, G. L.

Source: Anaesthesia, Volume 64, Number 12, December 2009 , pp. 1359-1362(4)

Publisher: Blackwell Publishing

Sudden death in patients receiving drugs tending to prolong the QT interval

Authors: Jolly, Kate; Gammage, Michael D.; Cheng, Kar Keung; Bradburn, Peter; Banting, Miriam V.; Langman, Michael J. S.

Source: British Journal of Clinical Pharmacology, Volume 68, Number 5, November 2009 , pp. 743-751(9)

Publisher: Blackwell Publishing

Relapse and Long-Acting Injectable Risperidone: A 1-Year Mirror Image Study with a National Claims Database in Taiwan

Authors: Su, Kuan-Pin; Chang, Hui-Chih; Tsai, Shih-Jen; Yen, Feng-Chang; Tang, Chao-Hsiun

Source: Value in Health, Volume 12, Supplement 3, November/December 2009 , pp. S118-S121(1)

Publisher: Blackwell Publishing

Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance: Part II

Author: Zhou, Shu-Feng

Source: Clinical Pharmacokinetics, Volume 48, Number 12, 1 December 2009 , pp. 761-804(44)

Publisher: Adis International

Treatment-resistant bipolar depression: towards a new definition

Authors: Pacchiarotti, I.; Mazzarini, L.; Colom, F.; Sanchez-Moreno, J.; Girardi, P.; Kotzalidis, G. D.; Vieta, E.

Source: Acta Psychiatrica Scandinavica, Volume 120, Number 6, December 2009 , pp. 429-440(12)

Publisher: Blackwell Publishing

Decision Resources predicts that the bipolar disorder drug market will decline by more than $US1 billion over the next decade.

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 591, 2009-11-14 , pp. 14-14(1)

Publisher: Adis International

Antipsychotics: Metabolic syndrome: case report

Source: Reactions, Volume 1, Number 1278, 2009-11-14 , pp. 7-7(1)

Publisher: Adis International

Antipsychotics/fluoxetine: Various toxicities: case report

Source: Reactions, Volume 1, Number 1278, 2009-11-14 , pp. 7-7(1)

Publisher: Adis International

A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently

Authors: Macfadden, Wayne; Alphs, Larry; Haskins, J Thomas; Turner, Norris; Turkoz, Ibrahim; Bossie, Cynthia; Kujawa, Mary; Mahmoud, Ramy

Source: Bipolar Disorders, Volume 11, Number 8, December 2009 , pp. 827-839(13)

Publisher: Blackwell Publishing

Mood stabilizers increase prepulse inhibition in DBA/2NCrl mice

Authors: Flood, Dorothy; Choinski, Matthew; Marino, Michael; Gasior, Maciej

Source: Psychopharmacology, Volume 205, Number 3, August 2009 , pp. 369-377(9)

Publisher: Springer

Early effects of mood stabilizers on the Akt/GSK-3β signaling pathway and on cell survival and proliferation

Authors: Aubry, Jean-Michel; Schwald, Michèle; Ballmann, Eladia; Karege, Félicien

Source: Psychopharmacology, Volume 205, Number 3, August 2009 , pp. 419-429(11)

Publisher: Springer

Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia

Authors: Uezato, Akihito; Meador-Woodruff, James H; McCullumsmith, Robert E

Source: Bipolar Disorders, Volume 11, Number 7, November 2009 , pp. 711-725(15)

Publisher: Blackwell Publishing

Antipsychotic use and the risk of hip/femur fracture: a population-based case-control study

Authors: Pouwels, S.; Staa, T.; Egberts, A.; Leufkens, H.; Cooper, C.; Vries, F.

Source: Osteoporosis International, Volume 20, Number 9, September 2009 , pp. 1499-1506(8)

Publisher: Springer